Advancing high-throughput anti-HCV drug screening: a novel dual-reporter HCV replicon model with real-time monitoring
Background and purpose: Hepatitis C virus (HCV) infection is a global health concern due to its substantial impact on morbidity and mortality. The burden of diseases related to HCV continues to escalate, particularly as infections progress to late-stage liver conditions, resulting in hepatocellular...
Saved in:
| Main Authors: | Kanokwan Chitsombat, Sarin Chimnaronk, Khanit Sa-ngiamsuntorn, Mullika Traidej Chomnawang, Krit Thirapanmethee |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Series: | Research in Pharmaceutical Sciences |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/RPS.RPS_249_23 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A scoping review on HCV screening strategies: population to screen and the test types
by: Saro Abdella Abrahim, et al.
Published: (2025-07-01) -
Threshold value of the anti-HCV test in the diagnosis of HCV infection
by: Özlem Kirişci, et al.
Published: (2019-10-01) -
IS ONLY REQUESTING AN ANTI-HCV TEST SUFFICIENT FOR HEPATITIS C SCREENING?
by: Rabia Deniz, et al.
Published: (2024-07-01) -
Elimination of HCV Infection: Recent Epidemiological Findings, Barriers, and Strategies for the Coming Years
by: Pietro Torre, et al.
Published: (2024-11-01) -
Investigation of Hepatitis C (HCV) Virus Epidemiology in the Capital City of Türkiye
by: Fatih Mehmet Akıllı
Published: (2024-12-01)